Sg Americas Securities, LLC Trevena Inc Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.41 - $0.63 $15,600 - $23,970	-38,049 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$0.57 - $1.29 $26,230 - $59,364	-46,019 Reduced 54.74%	38,049 $22,000
Q3 2021 Nov 01, 2021	BUY	$1.11 - $1.7 $93,315 - $142,915	84,068 New	84,068 $103,000
Q2 2018 Aug 07, 2018	SELL	$1.44 - $2.24 $36,542 - $56,844	-25,377 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$1.51 - $2.06 $20,240 - $27,612	13,404 Added 111.95%	25,377 $42,000
Q4 2017 Jan 24, 2018	SELL	$1.4 - $2.6 $9,466 - $17,581	-6,762 Reduced 36.09%	11,973 $19,000
Q3 2017 Nov 07, 2017	BUY	$2.22 - $2.79 $41,591 - $52,270	18,735	18,735 $48,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $281M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.